Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Sillaber

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Progress in Growth Factor Research|January 1, 1991
The growth and differentiation of mast cellsP Valent, C Sillaber, P Bettelheim
Blut|December 1, 1990
Why clinicians should be interested in interleukin-3P Valent, K Geissler, C Sillaber, et al.
Archives of Pathology & Laboratory Medicine|April 1, 1997
Bone marrow mastocytosis associated with an undifferentiated extramedullary tumor of hemopoietic originH P Horny, E Kaiserling, C Sillaber, et al.
European Journal of Clinical Investigation|August 5, 2004
Expression of angiogenic factors in chronic myeloid leukaemia: role of the bcr/abl oncogene, biochemical mechanisms, and potential clinical implicationsC Sillaber, M Mayerhofer, K J Aichberger, et al.
Blood|March 9, 2000
STAT5 activation contributes to growth and viability in Bcr/Abl-transformed cellsC Sillaber, F Gesbert, D A Frank, et al.
International Archives of Allergy and Immunology|November 1, 1994
Inhibition of stem cell factor dependent formation of human mast cells by interleukin-3 and interleukin-4C Sillaber, W R Sperr, H Agis, et al.
Wiener Klinische Wochenschrift|January 17, 1997
Rational use of polymerase chain reaction--based detection of viral genomes in patients with serologic markers of hepatitis B or C virus infectionF Pfeffel, C Oesterreicher, E Penner, et al.
Leukemia & Lymphoma|January 24, 2004
Low dose thalidomide in patients with relapsed or refractory multiple myelomaM Kees, G Dimou, C Sillaber, et al.
Blood|August 1, 1992
Type beta transforming growth factors promote interleukin-3 (IL-3)-dependent differentiation of human basophils but inhibit IL-3-dependent differentiation of human eosinophilsC Sillaber, K Geissler, R Scherrer, et al.
The Journal of Biological Chemistry|June 25, 1992
Characterization of prostaglandin (PG)-binding sites expressed on human basophils. Evidence for a prostaglandin E1, I2, and a D2 receptorI Virgolini, S Li, C Sillaber, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Progress in Growth Factor Research|January 1, 1991
The growth and differentiation of mast cellsP Valent, C Sillaber, P Bettelheim
Blut|December 1, 1990
Why clinicians should be interested in interleukin-3P Valent, K Geissler, C Sillaber, et al.
Archives of Pathology & Laboratory Medicine|April 1, 1997
Bone marrow mastocytosis associated with an undifferentiated extramedullary tumor of hemopoietic originH P Horny, E Kaiserling, C Sillaber, et al.
European Journal of Clinical Investigation|August 5, 2004
Expression of angiogenic factors in chronic myeloid leukaemia: role of the bcr/abl oncogene, biochemical mechanisms, and potential clinical implicationsC Sillaber, M Mayerhofer, K J Aichberger, et al.
Blood|March 9, 2000
STAT5 activation contributes to growth and viability in Bcr/Abl-transformed cellsC Sillaber, F Gesbert, D A Frank, et al.
International Archives of Allergy and Immunology|November 1, 1994
Inhibition of stem cell factor dependent formation of human mast cells by interleukin-3 and interleukin-4C Sillaber, W R Sperr, H Agis, et al.
Wiener Klinische Wochenschrift|January 17, 1997
Rational use of polymerase chain reaction--based detection of viral genomes in patients with serologic markers of hepatitis B or C virus infectionF Pfeffel, C Oesterreicher, E Penner, et al.
Leukemia & Lymphoma|January 24, 2004
Low dose thalidomide in patients with relapsed or refractory multiple myelomaM Kees, G Dimou, C Sillaber, et al.
Blood|August 1, 1992
Type beta transforming growth factors promote interleukin-3 (IL-3)-dependent differentiation of human basophils but inhibit IL-3-dependent differentiation of human eosinophilsC Sillaber, K Geissler, R Scherrer, et al.
The Journal of Biological Chemistry|June 25, 1992
Characterization of prostaglandin (PG)-binding sites expressed on human basophils. Evidence for a prostaglandin E1, I2, and a D2 receptorI Virgolini, S Li, C Sillaber, et al.
Pageof 5